HCM
HALO icon

Hollencrest Capital Management’s Halozyme HALO Stock Holding History

Hollencrest Capital Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-400
Closed -$26.9K – 1256
2025
Q4 		$26.9K Sell
400
-10
-2% -$673 ﹤0.01% 667
2025
Q3 		$30.1K Hold
410
– – ﹤0.01% 640
2025
Q2 		$21.3K Hold
410
– – ﹤0.01% 669
2025
Q1 		$26.2K Hold
410
– – ﹤0.01% 622
2024
Q4 		$19.6K Buy
+410
New +$21K ﹤0.01% 699

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hollencrest Capital Management's HALO Position: Q1 2026 in Review

Hollencrest Capital Management sold out of Halozyme (HALO) in Q1 2026, closing a stake of 400 shares — an estimated $26.9K sold.

Hollencrest Capital Management first reported a position in HALO in Q4 2024 and held it in 5 quarters. The position peaked at $30.1K in Q3 2025. 636 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Hollencrest Capital Management reported no remaining Halozyme position as of Q1 2026 after selling out during the quarter.
  • Hollencrest Capital Management sold 400 Halozyme shares in Q1 2026, an estimated $26.9K.
  • Hollencrest Capital Management first reported a position in Halozyme in Q4 2024 and held it in 5 quarters.
  • Hollencrest Capital Management's Halozyme position peaked at $30.1K in Q3 2025.
  • 636 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Hollencrest Capital Management's 13F filing for Q1 2026, filed 7 May 2026.